Russell Investments Group Ltd. Acquires 34,780 Shares of HCA Healthcare, Inc. $HCA

Russell Investments Group Ltd. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 538,054 shares of the company’s stock after acquiring an additional 34,780 shares during the period. Russell Investments Group Ltd. owned approximately 0.24% of HCA Healthcare worth $251,527,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Nordea Investment Management AB raised its stake in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after purchasing an additional 108,849 shares during the period. Hudson Bay Capital Management LP raised its stake in shares of HCA Healthcare by 154.5% in the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after purchasing an additional 2,849 shares during the period. Nomura Asset Management Co. Ltd. raised its stake in shares of HCA Healthcare by 6.2% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the period. Advisors Capital Management LLC raised its stake in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after purchasing an additional 2,604 shares during the period. Finally, CWA Asset Management Group LLC raised its stake in shares of HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after purchasing an additional 8,733 shares during the period. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 1.7%

Shares of NYSE HCA opened at $396.55 on Wednesday. The business’s 50 day moving average price is $426.45 and its two-hundred day moving average price is $471.57. The company has a market cap of $87.97 billion, a PE ratio of 13.64, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the company posted $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Wall Street Analyst Weigh In

Several analysts have issued reports on HCA shares. Mizuho lifted their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Truist Financial set a $413.00 target price on HCA Healthcare in a report on Thursday, June 4th. Barclays dropped their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Royal Bank Of Canada dropped their target price on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a report on Monday, April 27th. Finally, TD Cowen lowered their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, April 27th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.